These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27875388)

  • 61. Ospemifene for the treatment of vulvovaginal atrophy and dyspareunia in postmenopausal women.
    McLendon AN; Clinard VB; Woodis CB
    Pharmacotherapy; 2014 Oct; 34(10):1050-60. PubMed ID: 25052122
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R; Williams RS; Pan K; Mirkin S; Pickar JH
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Personal opinion: Treatment of vulvovaginal atrophy--are hidden interests and misinformation preventing better management?
    Pines A; Sturdee DW
    Climacteric; 2015; 18(6):802-4. PubMed ID: 26397968
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Irreversible change and tumor formation in the vaginal epithelium of mice induced by steroid hormones].
    Takasugi N
    Saishin Igaku; 1968 Mar; 23(3):522-31. PubMed ID: 5684917
    [No Abstract]   [Full Text] [Related]  

  • 65. [Value of cyto-hormonal smears in the conduct of androgenic treatment of women with breast cancer].
    Marsan C; Sicard A
    Presse Med (1893); 1969 Dec; 77(54):2033-6. PubMed ID: 5378459
    [No Abstract]   [Full Text] [Related]  

  • 66. [Intracrinology and dehydroepiandrosterone--a new perspective for the use of androgens in hormone replacement therapy in postmenopausal women].
    Perzyło K; Kulik-Rechberger B; Gałczyński K; Rechberger T
    Ginekol Pol; 2011 Sep; 82(9):690-5. PubMed ID: 22379930
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High bioavailability of dehydroepiandrosterone administered percutaneously in the rat.
    Labrie C; Flamand M; Bélanger A; Labrie F
    J Endocrinol; 1996 Sep; 150 Suppl():S107-18. PubMed ID: 8943794
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of the genitourinary syndrome of menopause.
    Palacios S; Mejía A; Neyro JL
    Climacteric; 2015; 18 Suppl 1():23-9. PubMed ID: 26366797
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.
    Bachmann GA; Komi JO;
    Menopause; 2010; 17(3):480-6. PubMed ID: 20032798
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens.
    Schmidt M; Weidler C; Naumann H; Anders S; Schölmerich J; Straub RH
    Arthritis Res Ther; 2005; 7(5):R938-48. PubMed ID: 16207335
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of long-term topical application of dehydroepiandrosterone (DHEA) and oral estrogens on morphology, cell proliferation, procollagen A1 and androgen receptor levels in rat skin.
    Berger L; El-Alfy M; Martel C; Labrie F
    Horm Mol Biol Clin Investig; 2010 Aug; 2(2):267-75. PubMed ID: 25961198
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Should Dehydroepiandrosterone Be Administered to Women?
    Wierman ME; Kiseljak-Vassiliades K
    J Clin Endocrinol Metab; 2022 May; 107(6):1679-1685. PubMed ID: 35254428
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis.
    Castagnetta LA; Carruba G; Granata OM; Stefano R; Miele M; Schmidt M; Cutolo M; Straub RH
    J Rheumatol; 2003 Dec; 30(12):2597-605. PubMed ID: 14719200
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sex steroid hormones differentially regulate nitric oxide synthase and arginase activities in the proximal and distal rabbit vagina.
    Traish AM; Kim NN; Huang YH; Min K; Munarriz R; Goldstein I
    Int J Impot Res; 2003 Dec; 15(6):397-404. PubMed ID: 14671657
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The intracrinology of breast cancer.
    McNamara KM; Sasano H
    J Steroid Biochem Mol Biol; 2015 Jan; 145():172-8. PubMed ID: 24751707
    [TBL] [Abstract][Full Text] [Related]  

  • 77. DHEA for postmenopausal women: a review of the evidence.
    Panjari M; Davis SR
    Maturitas; 2010 Jun; 66(2):172-9. PubMed ID: 20089375
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women.
    Goldstein I; Alexander JL
    J Sex Med; 2005 Sep; 2 Suppl 3():154-65. PubMed ID: 16422792
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [THE EFFECT OF THE SIMULTANEOUS ACTION OF ANDROGENS AND ESTROGENS ON THE VAGINAL EPITHELIUM IN WOMEN IN THE MENOPAUSE].
    DZIOBA A; GOLUDA M; SUCHY H
    Zentralbl Gynakol; 1965 Apr; 87():455-63. PubMed ID: 14308682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.